Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Isabella Giacchetto-Sasselli"'
Autor:
Luca Piccoli, Paolo Ferrari, Giovanni Piumatti, Sandra Jovic, Blanca Fernandez Rodriguez, Federico Mele, Isabella Giacchetto-Sasselli, Tatiana Terrot, Chiara Silacci-Fregni, Elisabetta Cameroni, Stefano Jaconi, Nicole Sprugasci, Istvan Bartha, Davide Corti, Mariagrazia Uguccioni, Antonio Lanzavecchia, Christian Garzoni, Olivier Giannini, Enos Bernasconi, Luigia Elzi, Emiliano Albanese, Federica Sallusto, Alessandro Ceschi
Publikováno v:
The Lancet Regional Health. Europe, Vol 1, Iss , Pp 100013- (2021)
Summary: Background: Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Methods: Between April 16 and 3
Externí odkaz:
https://doaj.org/article/3f0f61474ddf45c9aea56d4e2054cf3f
Autor:
Jesse D. Bloom, Fabio Benigni, Anna De Marco, Fabrizia Zatta, Laura E. Rosen, Stefano Jaconi, Istvan Bartha, Tyler N. Starr, Michael P. Housley, Elisabetta Cameroni, Julia di Iulio, Gyorgy Snell, Rana Abdelnabi, Davide Corti, Chiara Silacci Fregni, Jiayi Zhou, Katja Culap, Exequiel Dellota, Herbert W. Virgin, Nicole Sprugasci, John E. Bowen, Isabella Giacchetto-Sasselli, M. Alejandra Tortorici, David Veesler, Nadine Czudnochowski, Dora Pinto, Shi Yan Caroline Foo, Martina Beltramello, Colin Havenar-Daughton, Christian Saliba, Zhuoming Liu, Matteo Samuele Pizzuto, Samantha K Zepeda, Hannah Kaiser, Amalio Telenti, Johan Neyts, Roberta Marzi, Martin Montiel-Ruiz, Alexandra C. Walls, Michael A. Schmid, Z. Wang, Sean P. J. Whelan, Barbara Guarino, Eneida Vetti, Florian A. Lempp, Amin Addetia
Publikováno v:
Nature
The recent emergence of SARS-CoV-2 variants of concern1-10 and the recurrent spillovers of coronaviruses11,12 into the human population highlight the need for broadly neutralizing antibodies that are not affected by the ongoing antigenic drift and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c30b4d574f2487b773509f345bc13f3
https://europepmc.org/articles/PMC9341430/
https://europepmc.org/articles/PMC9341430/
Autor:
Luigia Elzi, Luca Piccoli, Giovanni Piumatti, Alessandro Ceschi, Olivier Giannini, Nicole Sprugasci, Federico Mele, Christian Garzoni, Antonio Lanzavecchia, Emiliano Albanese, Enos Bernasconi, Tatiana Terrot, Mariagrazia Uguccioni, Davide Corti, Chiara Silacci-Fregni, Isabella Giacchetto-Sasselli, Federica Sallusto, Istvan Bartha, Paolo Ferrari, Elisabetta Cameroni, Sandra Jovic, Blanca Fernandez Rodriguez, Stefano Jaconi
Publikováno v:
The Lancet Regional Health-Europe, 1
The Lancet Regional Health-Europe
The Lancet Regional Health. Europe, Vol 1, Iss, Pp 100013-(2021)
The Lancet Regional Health-Europe
The Lancet Regional Health. Europe, Vol 1, Iss, Pp 100013-(2021)
Background Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Methods Between April 16 and 30, 2020 we
Autor:
Jacques Dumas, Thomas Bertrand, Roger Geiger, Michael Auer, Antonio Lanzavecchia, Isabella Giacchetto-Sasselli, David Jarrossay, Federica Sallusto, Stéphanie Pouzieux, Antonino Cassotta, Luca Piccoli, Chiara Silacci-Fregni, Mathilde Foglierini, Florian Deisenhammer, Matteo Gastaldi, Josiane Le Parc, Blanca Fernandez Rodriguez, Paul Ferrari, Diego Franciotta, Vincent Mikol
Publikováno v:
Nature medicine
Nature Medicine
Nature Medicine
Natalizumab (NZM), a humanized monoclonal IgG4 antibody to α4 integrins, is used to treat patients with relapsing-remitting multiple sclerosis (MS)1,2, but in about 6% of the cases persistent neutralizing anti-drug antibodies (ADAs) are induced lead
Autor:
Tyler N. Starr, Michael P. Housley, Michael A. Schmid, Roberta Marzi, Martin Montiel-Ruiz, Katja Culap, Hanna Kaiser, Matteo Samuele Pizzuto, Nicole Sprugasci, Barbara Guarino, David Veesler, Fabio Benigni, Johan Neyts, Nadine Czudnochowski, Eneida Vetti, Exequiel Dellota, Martina Beltramello, Colin Havenar-Daughton, M. Alejandra Tortorici, Isabella Giacchetto-Sasselli, Florian A. Lempp, Caroline S. Foo, Dora Pinto, Anna De Marco, Gyorgy Snell, Julia di Iulio, Stefano Jaconi, Rana Abdelnabi, Z. Wang, Jiayi Zhou, Chiara Silacci Fregni, Amalio Telenti, Fabrizia Zatta, Jesse D. Bloom, Laura E. Rosen, Davide Corti, Herbert W. Virgin, Alexandra C. Walls, Christian Saliba, Samantha K Zepeda, Sean P. J. Whelan, Amin Addetia, John E. Bowen, Istvan Bartha, Elisabetta Cameroni, Zhuoming Liu
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
The recent emergence of SARS-CoV-2 variants of concern (VOC) and the recurrent spillovers of coronaviruses in the human population highlight the need for broadly neutralizing antibodies that are not affected by the ongoing antigenic drift and that ca
Autor:
Gloria Agatic, Giosiana Codoni, Antonio Lanzavecchia, Andrea Minola, Steven J. Gamblin, Lesley F. Haire, Jarrod Voss, Debora Pinna, John J. Skehel, Isabella Giacchetto-Sasselli, Fabrizia Vanzetta, Nigel J. Temperton, Davide Corti, David Jarrossay, Patrick J. Collins, Sebastien G. Vachieri, Chiara Silacci, Siro Bianchi, Annalisa Macagno, Blanca Fernandez-Rodriguez, Johannes P. M. Langedijk, Federica Sallusto, Lesley J. Calder
Publikováno v:
Science
The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. Using a single-cell culture method for screening large numbers of human plasma cells, we isolated